AAAAAA
Results:
1-9
|
Results: 9
Authors:
DIAZ RM
VILE R
Citation: Rm. Diaz et R. Vile, EURO TARGETING IN LEIDEN - THE 4TH MEETING OF THE EWGT, UNIVERSITY-OF-LEIDEN, 14-17 NOVEMBER 1996, Gene therapy, 4(6), 1997, pp. 501-503
Authors:
SUNASSEE K
VILE R
Citation: K. Sunassee et R. Vile, TUMOR ANGIOGENESIS - HITTING CANCER WHERE IT HURTS, Current biology, 7(5), 1997, pp. 282-285
Authors:
SUNASSEE K
DIAZ RM
MORLING F
COSSET FL
RUSSELL S
VILE R
Citation: K. Sunassee et al., DUAL TARGETING OF RETROVIRUSES TO MELANOMA-CELLS - VIA CELL-SURFACE TARGETING AND TISSUE-SPECIFIC EXPRESSION OF THERAPEUTIC GENES, Cancer gene therapy, 4(5), 1997, pp. 325-325
Authors:
MARTIN LA
VILE R
LEMOINE NR
SIKORA K
PANDHA HS
Citation: La. Martin et al., GENETIC PRODRUG ACTIVATION THERAPY, Lancet, 350(9094), 1997, pp. 1793-1794
Authors:
VILE R
Citation: R. Vile, CANCER-THERAPY - LESS BLOOD MEANS MORE SANGUINITY, Current biology, 5(1), 1995, pp. 10-13
Authors:
CASTLEDEN S
TUSZYNSKI A
CHONG H
HART I
VILE R
Citation: S. Castleden et al., IN-VIVO GENE-THERAPY OF METASTATIC MELANOMA USING THE HSVTK GENE BY COACTIVATION OL ANTITUMOR IMMUNITY, European journal of cancer, 31A, 1995, pp. 34-34
Authors:
MILLER N
VILE R
Citation: N. Miller et R. Vile, TARGETED VECTORS FOR GENE-THERAPY, The FASEB journal, 9(2), 1995, pp. 190-199
Authors:
VILE R
MILLER N
CHERNAJOVSKY Y
HART I
Citation: R. Vile et al., A COMPARISON OF THE PROPERTIES OF DIFFERENT RETROVIRAL VECTORS CONTAINING THE MURINE TYROSINASE PROMOTER TO ACHIEVE TRANSCRIPTIONALLY TARGETED EXPRESSION OF THE HSVTK OR IL-2 GENES, Gene therapy, 1(5), 1994, pp. 307-316
Authors:
VILE R
RUSSELL SJ
Citation: R. Vile et Sj. Russell, GENE-TRANSFER TECHNOLOGIES FOR THE GENE-THERAPY OF CANCER, Gene therapy, 1(2), 1994, pp. 88-98
Risultati:
1-9
|